Show simple item record

dc.contributor.authorAnyanwu, Chinekwu
dc.contributor.authorMotamedi, Gholam K.
dc.date.accessioned2019-04-01T11:58:24Z
dc.date.available2019-04-01T11:58:24Z
dc.date.issued2018-03-21
dc.identifier.citationAnyanwu, C.; Motamedi, G.K. Diagnosis and Surgical Treatment of Drug-Resistant Epilepsy. Brain Sci. 2018, 8, 49.
dc.identifier.urihttp://hdl.handle.net/10919/88762
dc.description.abstractDespite appropriate trials of at least two antiepileptic drugs, about a third of patients with epilepsy remain drug resistant (intractable; refractory). Epilepsy surgery offers a potential cure or significant improvement to those with focal onset drug-resistant seizures. Unfortunately, epilepsy surgery is still underutilized which might be in part because of the complexity of presurgical evaluation. This process includes classifying the seizure type, lateralizing and localizing the seizure onset focus (epileptogenic zone), confirming the safety of the prospective brain surgery in terms of potential neurocognitive deficits (language and memory functions), before devising a surgical plan. Each one of the above steps requires special tests. In this paper, we have reviewed the process of presurgical evaluation in patients with drug-resistant focal onset epilepsy.en_US
dc.format.mimetypeapplication/pdf
dc.language.isoen_US
dc.publisherMDPI
dc.rightsCreative Commons Attribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleDiagnosis and Surgical Treatment of Drug-Resistant Epilepsyen_US
dc.typeArticle - Refereed
dc.date.updated2019-03-29T19:40:00Z
dc.title.serialBrain Science
dc.identifier.doihttps://doi.org/10.3390/brainsci8040049
dc.type.dcmitypeText


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution 4.0 International
License: Creative Commons Attribution 4.0 International